Quarterly Result23 May 2026, 07:51 pm
Anupam Rasayan: FY26 Results, ₹1.5 Dividend & Bliss GVS Acquisition
AI Summary
Anupam Rasayan India Ltd approved audited financial results for the quarter and year ended March 31, 2026. The board recommended a final dividend of ₹1.5 per equity share (15% of face value). They also approved the re-appointment of internal and cost auditors. Furthermore, the company approved the acquisition of up to 74.20% of Bliss GVS Pharma Limited and the issuance of ₹160 Crore in Non-Convertible Debentures on a private placement basis. Vishal Thakkar resigned as Deputy CFO.
Key Highlights
- Anupam Rasayan approved audited standalone and consolidated financial results for FY26.
- A final dividend of ₹1.5 per equity share (15% of face value) was recommended, subject to shareholder approval.
- The company will acquire up to 74.20% of Bliss GVS Pharma Limited.
- ₹160 Crore will be raised through the issuance of secured, rated, unlisted, redeemable, Non-Convertible Debentures on a private placement basis.
- Vishal Thakkar resigned from the post of Deputy Chief Financial Officer.
Price Impact
More from ANURAS